Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis

Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis

The rapid emergence of COVID-19 variants of concern (VOCs) has hindered vaccine uptake. To inform policy, we investigated the effectiveness of the BNT162b2 vaccination among adolescents against symptomatic and severe COVID-19 diseases using mostly real-world data (15 studies). We searched internatio...

Full description

Bibliographic Details
Main Authors: Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
sars-cov-2
children
adolescents
immunization
post marketing surveillance
efficacy
Online Access:http://dx.doi.org/10.1080/21645515.2023.2214495

Internet

http://dx.doi.org/10.1080/21645515.2023.2214495

Similar Items